Please assess the completion status of the following clinical trial:

Trial Title: Evaluating the Efficacy of Lateral Heel Wedges of Osteoarthritis of the Knee

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients 30 years or older with medial compartment knee Osteoarthritis (unilateral) and Grade 4 Kellgren-Lawrence39 radiographic changes presenting for treatment of knee pain.~* Range of motion knee-flexion beyond 100 degrees and not lacking more than 15 degrees of extension.~* Subtalar and forefoot motion permitting foot/ankle eversion with weight bearing.~* Sufficient shoe toe box height to allow space for the insole and therefore comfort and compliance.~* Passive laxity of medial capsule and collateral ligament by knee extension test.~Exclusion Criteria:~* All other forms of knee arthritis other than OA.~* Knee Instability- medial pseudo-opening of greater than grade 1 or detectable Anterior-posterior instability.~* Less than Grade 4 Kellgren-Lawrence radiographic changes in the medial compartment of the knee39.~* Grade 2 or greater Kellgren-Lawrence radiographic39 involvement of the patellofemoral or lateral compartment.~* Inadequate knee range of motion~* Balance problems requiring the use of a walker or wheel chair - ambulation with aid~* Diabetics with peripheral neuropathy~* Knee surgery within the past year~* Intraarticular steroid injection or visco supplementation within 6 months~* Stiff subtalar or forefoot joints - clinical test~* Inadequate shoe toe box depth to accommodate the test or control inserts~* Charcot joint~* Fixed contracture of the medial capsule and/or collateral ligament- clinical test

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 100 Years
- Healthy Volunteers: t

Study Arms:
- Wedge Insert (Type: EXPERIMENTAL): Patients will receive a wedge insert
- Flat insert (Type: PLACEBO_COMPARATOR): Patients will receive a flat insert

Based on this trial design, predict the completion outcome and termination type (if applicable).